Novonix (NVX) Total Current Liabilities (2020 - 2025)

Novonix (NVX) has reported Total Current Liabilities for 6 consecutive years, with $83.6 million the latest figure, recorded in Q4 2025.

• Quarterly Total Current Liabilities rose 80.7% year-over-year to $83.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $83.6 million (up 80.7% YoY) and the FY2025 annual result came in at $83.6 million, up 80.7% from the prior year.
• Total Current Liabilities grew to $83.6 million in Q4 2025 per NVX's latest filing, from $76.5 million in the prior quarter.
• Over the last five years, Total Current Liabilities for NVX reached as high as $83.6 million in Q4 2025 and fell as low as $3.7 million in Q4 2021.
• A 5-year average of $28.3 million and a median of $8.9 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities slipped 23.05% — and 2025, when it surged 713.28%.
• Year by year, Total Current Liabilities stood at $3.7 million in 2021, then soared by 126.94% to $8.5 million in 2022, then soared by 340.17% to $37.3 million in 2023, then gained by 24.1% to $46.2 million in 2024, then surged by 80.7% to $83.6 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $83.6 million, $76.5 million, and $46.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.